We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
–
AUM
$281M
AUM Growth
-$10.8M
Cap. Flow
-$24.3M
Cap. Flow %
-8.63%
Top 10 Hldgs %
39.74%
Holding
374
New
13
Increased
43
Reduced
92
Closed
35

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.29M
2
HP icon
Helmerich & Payne
HP
+$704K
3
PYPL icon
PayPal
PYPL
+$644K
4
GILD icon
Gilead Sciences
GILD
+$512K
5
BIVV
Bioverativ Inc. Common Stock
BIVV
+$359K

Top Sells

Rank Stock Value
1
PVTBP
PrivateBancorp, Inc. Capital Trust IV Trust Preferred
PVTBP
+$5.61M
2
GS.PRB.CL
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
+$4.47M
3
AWH
Allied World Assurance Co Hld Lt
AWH
+$3.73M
4
WFC.PRJ.CL
Wells Fargo & Company
WFC.PRJ.CL
+$2.8M
5
USB.PRM
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 26.69%
2 Healthcare 14.97%
3 Consumer Staples 13.1%
4 Miscellaneous 10.52%
5 Financials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSK icon
51
State Street SPDR ICE Preferred Securities ETF
PSK
$678M
$1.08M 0.38%
24,525
-500
-2% -$21.8K
GOOG icon
52
Alphabet (Google) Class C
GOOG
$4.19T
$1.03M 0.37%
24,720
+1,100
+5% +$45.1K
VRTX icon
53
Vertex Pharmaceuticals
VRTX
$137B
$979K 0.35%
8,950
-75
-0.8% -$6.6K
BPFHP
54
DELISTED
Boston Private Financial Holdings, Inc.
BPFHP
$927K 0.33%
36,018
-250
-0.7% -$6.39K
OXY icon
55
Occidental Petroleum
OXY
$59.1B
$925K 0.33%
14,598
+58
+0.4% +$3.86K
BNY
56
Bank of New York Mellon
BNY
$110B
$865K 0.31%
18,318
-1,238
-6% -$57.9K
AMGN icon
57
Amgen
AMGN
$234B
$841K 0.3%
5,127
-187
-4% -$31.1K
MMP
58
DELISTED
Magellan Midstream Partners, L.P.
MMP
$830K 0.3%
10,788
-100
-0.9% -$7.76K
RMD icon
59
ResMed
RMD
$34.7B
$816K 0.29%
11,340
+350
+3% +$24.2K
GILD icon
60
Gilead Sciences
GILD
$181B
$807K 0.29%
11,875
+7,275
+158% +$512K
DUK icon
61
Duke Energy
DUK
$93.8B
$733K 0.26%
8,932
– –
NVO
62
Novo Nordisk
NVO
$202B
$725K 0.26%
42,300
-200
-0.5% -$3.48K
MSM icon
63
MSC Industrial Direct
MSM
$6.66B
$708K 0.25%
6,885
-550
-7% -$55.7K
EW icon
64
Edwards Lifesciences
EW
$52B
$659K 0.23%
21,030
+1,305
+7% +$40.9K
FLO icon
65
Flowers Foods
FLO
$1.51B
$649K 0.23%
33,451
-200
-0.6% -$3.93K
GNTX icon
66
Gentex
GNTX
$4.78B
$631K 0.22%
29,600
-13,500
-31% -$283K
EMB icon
67
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$628K 0.22%
5,520
-50
-0.9% -$5.63K
BAC icon
68
Bank of America
BAC
$436B
$625K 0.22%
26,490
-834
-3% -$19.8K
KMI icon
69
Kinder Morgan
KMI
$70.3B
$611K 0.22%
28,089
+1,450
+5% +$31.7K
WELL icon
70
Welltower
WELL
$172B
$549K 0.2%
7,746
– –
DE icon
71
Deere & Co
DE
$170B
$509K 0.18%
4,675
-350
-7% -$37.9K
VZ icon
72
Verizon
VZ
$208B
$483K 0.17%
9,915
+410
+4% +$20.6K
XBI icon
73
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$483K 0.17%
6,970
-3,025
-30% -$203K
RDS.B
74
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$483K 0.17%
8,645
+300
+4% +$17K
WFC icon
75
Wells Fargo
WFC
$262B
$468K 0.17%
8,400
-500
-6% -$28.4K
1 2
3
4 5

Similar funds

BPM
Bowling Portfolio Management Cincinnati, Ohio $364M AUM 7.07% 1-Year Est. Return
S
Surevest Los Angeles, California $368M AUM 13.7% 1-Year Est. Return
ACM
Axar Capital Management New York $304M AUM 38.78% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return
AW
ACG Wealth Atlanta, Georgia $437M AUM 11.28% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
SMG
Spectrum Management Group Indianapolis, Indiana $460M AUM 10.37% 1-Year Est. Return

American Research & Management Company's Q1 2017 Portfolio in Review

As of Q1 2017, American Research & Management Company held 374 positions worth $281M, down 3.7% from $292M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

American Research & Management Company withdrew a net $24.3M in Q1 2017, closing 35 positions and reducing 92 holdings. Its most notable exit was PrivateBancorp, Inc. Capital Trust IV Trust Preferred, an estimated $5.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, American Research & Management Company opened a new position in Bioverativ Inc. Common Stock worth $397K.

  • American Research & Management Company's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 7,291 shares worth $397K.
  • American Research & Management Company added most to NVIDIA in Q1 2017, an estimated $1.29M increase.
  • American Research & Management Company's biggest Q1 2017 reduction was Allied World Assurance Co Hld Lt, cutting an estimated $3.73M.
  • American Research & Management Company fully exited PrivateBancorp, Inc. Capital Trust IV Trust Preferred in Q1 2017, selling an estimated $5.61M.
  • American Research & Management Company's ten largest holdings make up 40% of its $281M portfolio in Q1 2017.
  • American Research & Management Company opened 13 new positions and closed 35 in Q1 2017.
  • American Research & Management Company's portfolio value fell 3.7% quarter-over-quarter to $281M.

Based on American Research & Management Company's 13F filing for Q1 2017, filed 17 Apr 2017.